Lokaal uitgebreid faciaal basaalcelcarcinoom met verrassende respons op R-CHOP

M. C. Urgert; M. Nijland; H. C. De Vijlder; G. F.H. Diercks; A. K.L. Reyners; J. B. Terra

Lokaal uitgebreid faciaal basaalcelcarcinoom met verrassende respons op R-CHOP

Translated title of the contribution: Locally advanced basal cell carcinoma of the face with surprising response to R-CHOP

M. C. Urgert^*, M. Nijland, H. C. De Vijlder, G. F.H. Diercks, A. K.L. Reyners, J. B. Terra

^*Corresponding author for this work

Translational Immunology Groningen (TRIGR)

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Treatment of choice for high risk basal cell carcinoma (BCC) of the face is Mohs micrographic surgery. Radiotherapy can be applied when surgery will result in cosmetic and/or functional morbidity. Patients with locally advanced or metastatic BCC can be treated with vismodegib or sonidegib. R-CHOP is used frequently in the treatment of several B-cell non-Hodgkin lymphomas, but effectiveness in the treatment of BCC is unknown. Here we present an impressive clinical and histological response of a locally advanced BCC of the face after treatment with R-CHOP for diffuse large B-cell lymphoma.

Translated title of the contribution	Locally advanced basal cell carcinoma of the face with surprising response to R-CHOP
Original language	Dutch
Pages (from-to)	308-311
Number of pages	4
Journal	Nederlands Tijdschrift voor Dermatologie en Venereologie
Volume	27
Issue number	6
Publication status	Published - 2017

Access to Document

https://www.scopus.com/record/display.uri?eid=2-s2.0-85025803195&origin=inward&txGid=431521f286aa78f6aa85e3c5fe479ee4

Handle.net

Persistent link

Cite this

Urgert, M. C., Nijland, M., De Vijlder, H. C., Diercks, G. F. H., Reyners, A. K. L., & Terra, J. B. (2017). Lokaal uitgebreid faciaal basaalcelcarcinoom met verrassende respons op R-CHOP. Nederlands Tijdschrift voor Dermatologie en Venereologie, 27(6), 308-311. https://www.scopus.com/record/display.uri?eid=2-s2.0-85025803195&origin=inward&txGid=431521f286aa78f6aa85e3c5fe479ee4

@article{769816e436aa45f0a751a81ad4ecaf2a,

title = "Lokaal uitgebreid faciaal basaalcelcarcinoom met verrassende respons op R-CHOP",

abstract = "Treatment of choice for high risk basal cell carcinoma (BCC) of the face is Mohs micrographic surgery. Radiotherapy can be applied when surgery will result in cosmetic and/or functional morbidity. Patients with locally advanced or metastatic BCC can be treated with vismodegib or sonidegib. R-CHOP is used frequently in the treatment of several B-cell non-Hodgkin lymphomas, but effectiveness in the treatment of BCC is unknown. Here we present an impressive clinical and histological response of a locally advanced BCC of the face after treatment with R-CHOP for diffuse large B-cell lymphoma.",

author = "Urgert, {M. C.} and M. Nijland and {De Vijlder}, {H. C.} and Diercks, {G. F.H.} and Reyners, {A. K.L.} and Terra, {J. B.}",

year = "2017",

language = "Dutch",

volume = "27",

pages = "308--311",

journal = "Nederlands Tijdschrift voor Dermatologie en Venereologie",

issn = "0925-8604",

publisher = "DCHG Partners in Mediscne Communicatie",

number = "6",

}

Urgert, MC, Nijland, M, De Vijlder, HC, Diercks, GFH , Reyners, AKL & Terra, JB 2017, 'Lokaal uitgebreid faciaal basaalcelcarcinoom met verrassende respons op R-CHOP', Nederlands Tijdschrift voor Dermatologie en Venereologie, vol. 27, no. 6, pp. 308-311. <https://www.scopus.com/record/display.uri?eid=2-s2.0-85025803195&origin=inward&txGid=431521f286aa78f6aa85e3c5fe479ee4>

TY - JOUR

T1 - Lokaal uitgebreid faciaal basaalcelcarcinoom met verrassende respons op R-CHOP

AU - Urgert, M. C.

AU - Nijland, M.

AU - De Vijlder, H. C.

AU - Diercks, G. F.H.

AU - Reyners, A. K.L.

AU - Terra, J. B.

PY - 2017

Y1 - 2017

N2 - Treatment of choice for high risk basal cell carcinoma (BCC) of the face is Mohs micrographic surgery. Radiotherapy can be applied when surgery will result in cosmetic and/or functional morbidity. Patients with locally advanced or metastatic BCC can be treated with vismodegib or sonidegib. R-CHOP is used frequently in the treatment of several B-cell non-Hodgkin lymphomas, but effectiveness in the treatment of BCC is unknown. Here we present an impressive clinical and histological response of a locally advanced BCC of the face after treatment with R-CHOP for diffuse large B-cell lymphoma.

AB - Treatment of choice for high risk basal cell carcinoma (BCC) of the face is Mohs micrographic surgery. Radiotherapy can be applied when surgery will result in cosmetic and/or functional morbidity. Patients with locally advanced or metastatic BCC can be treated with vismodegib or sonidegib. R-CHOP is used frequently in the treatment of several B-cell non-Hodgkin lymphomas, but effectiveness in the treatment of BCC is unknown. Here we present an impressive clinical and histological response of a locally advanced BCC of the face after treatment with R-CHOP for diffuse large B-cell lymphoma.

M3 - Article

AN - SCOPUS:85025803195

SN - 0925-8604

VL - 27

SP - 308

EP - 311

JO - Nederlands Tijdschrift voor Dermatologie en Venereologie

JF - Nederlands Tijdschrift voor Dermatologie en Venereologie

IS - 6

ER -

Lokaal uitgebreid faciaal basaalcelcarcinoom met verrassende respons op R-CHOP

Abstract

Access to Document

Handle.net

Fingerprint

Cite this